Russian Journal of DentistryRussian Journal of DentistryРоссийский стоматологический журнал1728-28022413-2934Eco-Vector4207210.18821/1728-28022016;20(3):165-168ArticlesСтатьиResearch ArticleRole nitrogen oxide and reactive nitrogen species in cancerogenesis of oral mucous membraneРоль оксида азота (II) и его активных метаболитов в канцерогенезе слизистой оболочки полости ртаBaydikO. DБайдикОльга Дмитриевна

Dr. Sci. Med., Associate professor of the Department of Dentistry, “Siberian State Medical University”

д-р мед. наук, доцент кафедры стоматологии Сибирского государственного медицинского университета

olgabajdik@yandex.ruTitarenkoM. AТитаренкоМ. АSysolyatinP. GСысолятинП. Г”Siberian state medical University”ГБОУ ВПО «Сибирский государственный медицинский университет» Минздрава России”Novosibirsk state medical University”ГБОУ ВПО «Новосибирский государственный медицинский университет»15062016203VOL 20, NO3 (2016)ТОМ 20, №3 (2016)16516804082020Copyright ©; 2016, Eco-VectorCopyright ©; 2016, ООО "Эко-Вектор"2016Eco-VectorООО "Эко-Вектор"https://rjdentistry.com/1728-2802/article/view/42072

Effects NO and reactive nitrogen species for screen method ofprecancer diseases of oral mucous membrane were presented, value of risk transformation in cancer in situ, drafting ofprognosis disease and expediency forfurther researches were showed in this point line.

В статье представлены эффекты NO и его активных метаболитов в качестве скринингового метода диагностики предраковых заболеваний слизистой оболочки полости рта, оценки риска трансформации в cancer in situ, для составления прогноза течения заболевания, а также показана целесообразность проведения дальнейших исследований в этом направлении.

reviewnitrogen oxideapoptosisantioxidant systembiomarkerscancerogenesisобзороксид азотаапоптозантиоксидантная системабиомаркерыканцерогенезВавилова Т.П., Янушевич О.О., Островская И.Г. Слюна. Аналитические возможности и перспективы. М.: БИНОМ; 2014.Ohashi M., Iwase M., Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J. Oral Pathol. Med. 1999; 28: 355-9. Available at: http://onlinelibrary.wiley.com.sci-hub.io/doi/10.1111/j.1600-0714.1999.tb02053.x/abstractTuteja N., Chandra M., Tuteja R., Miska M.K. Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology. J. Biomed. Biotechnol. 2004; 4: 227-37. Available at: http://dx.Doi.org/10.1155/S1110724304402034Moncada S., Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 2006; (1): 193-201. Doi:10.1038/sj.bjp.0706458.Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 1987; 84: 9265-9. Available at: http://www.pnas.org.sci-hub.io/content/84/24/9265.shortPalmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature. 1987; 327: 524-6. Available at: http://www.nature.com.sci-hub.io/nature/journal/v327/n6122/abs/327524a0.htmlKorde S., Sridharan G., Gadbail A., Poornima V. Nitric oxide and oral cancer: A review. Oral Oncol. 2012; 48: 475-83. Doi:10.1016/j.oraloncology.2012.01.003.Metwaly H., Ebrahem A.-M., Saku T. Vascular endothelial growth factor (VEGF) and inducible nitric oxidesynthase (iNOS) in oral lichen planus: An immunohistochemical studyfor the correlation between vascular and inflammatory reactions. J. Oral Maxillofac. Surg. Med. Pathol. 2014; 26 (3): 390-6. Available at: http://dx.Doi.org/10.1016/j.ajoms.2013.09.009Sessa W.C., Prichard K., Seyedi N., Wang J. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 1994; 74: 349-53. Available at: http://circres.ahajournals.org.sci-hub.io/content/74/2/349.shortManisundar N., Julius A., Amudhan A., Hemalatha V.T., Manigandan T. Nitric oxide as an inflammatory biomarker in oral and systemic diseases - a systematic review. Middle-East J. Sci. Res. 2014; 20 (7): 881-6. Doi:10.5829/idosi.mejsr.2014.20.07.82174.Brennan P.A. Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2000; 90: 624-9. Doi:10.1067/moe.2000.108800.Jaiswal M., LaRusso N.F., Gores G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001; 281: 626-34. Available at: http://ajpgi.physiology.org.sci-hub.io/content/ajpgi/281/3/G626.full.pdfBeevi S.S., Rasheed M.H., Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin. Chim. Acta. 2007; 375: 119-23. Doi:10.1016/j.cca.2006.06.028.Hassan I., Keen A., Majid S., Hassan T. Evaluation of the antioxidant status in patients of lichen planus in Kashmir valley - A hospital based study. J. Saudi Soc. Dermatol. Dermatol. Surg. 2013; 17: 13-6. Doi: 10.1016/j.jssdds.2012.12.002.Nagler R.M., Klein I., Zarzhevsky N., Drigues N., Reznick A.Z. Characterization of the differentiated antioxidant profile of human saliva. Free Radic. Biol. Med. 2002; 32: 268-77. Available at: http://www.sciencedirect.com.sci-hub.io/science/article/pii/S0891584901008061Sturgis E.M., Wei Q. Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr. Opin. Oncol. 2002; 4 (3): 310-7. Available at: http://journals.lww.com.sci-hub.io/co-oncology/Abstract/2002/05000/Genetic_susceptibility_molecular_epidemiology_of.10.aspxSalian V., Demeri F., Kumari S. Estimation of salivary nitric oxide and uric acid levels in oral squamous cell carcinoma and healthy controls. Clin. Cancer Invest. J. 2015; 4 (4): 516-9. Doi: 10.4103/2278-0513.158456.Xia D.S., Deng D.J., Wang S.L. Destruction of parotid glands affects nitrate and nitrite metabolism. J. Dent. Res. 2003; 82: 101-5. Available at: http://jdr.sagepub.com.sci-hub.io/content/82/2/101.shortPanjwani S., Bagewadi A., Keluskar V., Malik R., Rai S., Misra D. Estimation and comparison of levels of salivary nitric oxide in patients with oral lichen planus and controls. Int. J. Prev. Med. 2013; 4 (6): 710-4. Available at: http://www.ncbi.nlm.nih.gov.sci-hub.io/pmc/articles/PMC3733040Bansal S.K. Correlation between nitric oxide level and stress in lichen planus patients. J. Adv. Med. Dent. Sci. 2014; 1 (2): 38-41. Available at: http://www.jamdsr.com/pdf1/CorrelationbetweennitricoxidelevelandstressinLichenPlanuspatients2. pdfPatel B.P., Rawal U.M., Rawal R.M., Shukla S.N., Patel P.S. Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer. Am. J. Clin. Oncol. 2008; 31 (5): 454-9. Doi: 10.1097/COC.0b013e31816a61da.Rasheed M.H., Beevi S.S., Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol. 2007; 43: 333-8. Doi: 10.1016/j.oraloncology.2006.02.013.Banerjee A.G., Gopalakrishnan V.K., Vishwanatha J.K. Inhibition of nitric oxide-induced apoptosis by nicotine in oral epithelial cells. Mol. Cell. Biochem. 2007; 305: 113-21. Doi: 10.1007/s11010-007-9534-2.Korde S.D., Basak A., Chaudhary M., Goyal M., Vagga A. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology. 2011; 80: 382-9. Doi: 10.1159/000329811.Hashibe M., Brennan P., Benhamou S., Castellsague X., Chen C., Curado M.P. et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. J. Natl. Cancer Inst. 2007; 99 (10): 777-89. Doi: 10.1093/jnci/djk179.Singhal P.C., Patel P., Nаhаr N., Franki N., Kapasi A., Reddy K. et al. Ethanol-induced neutrophil apoptosis is mediated through nitric oxide. J. Leukoc. Biol. 1999; 66: 930-6. Available at: http://www.jleukbio.org.sci-hub.io/content/66/6/930.shortChoi B.M., Pae H.O., Jang S.I., Kim Y.M., Chung H.T. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Biol. 2002; 35: 116-26. Doi: 10.5483/BMBRep.2002.35.1.116.Bentz B.G., Chandra R., Haines G.K., Robinson A.M., Shah P.B.S., Radosevich J.A. Nitric oxide and apoptosis during human head and neck squamous cell carcinoma development. Am. J. Otolaryngol. 2002; 23: 4-11. Doi: 10.1053/ajot.2002.28772.Calenic B., Okamura K., Yaegakia K., Tovaru S., Tanaka T., Imai T. Role of p53-mediated apoptotic pathway in oral lichen planus: Relationship among pro-apoptotic, anti-apoptotic, and keratinocytic markers. J. Oral Maxillofac. Surg. Med. Pathol. 2014; 26: 221-7. Available at: http://dx.Doi.org/10.1016/j.ajoms.2013.06.009Chaiyarit P., Ma N., Hiraku Y., Pinlaor S., Yongvanit P., Jintakanon D. et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Scie. 2005; 96 (9): 553-9. Doi: 10.1111/j.1349-7006.2005.00096.x.Chen Y.-K., Hsuen S.-S., Lin L.-M. Increased expression of inducible nitric oxide synthase for human oral submucous fibrosis, verrucous hyperplasia, and verrucous carcinoma. Int. J. Oral Maxillofac. Surg. 2002; 31 (4): 419-22. Doi: 10.1054/ijom.2002.024.Connelly S.T., Macabeo-Ong M., Dekker N., Jordan R.C.K., Schmidt B.L. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol. 2005; 41: 261-7. Doi: 10.1016/j.oraloncology.2004.09.007.Maejima Y., Adachi S., Morikawa K., Ito H., Isobe M. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J. Mol. Cell. Cardiol. 2005; 38: 163-74. Doi: 10.1016/j.yjmcc.2004.10.012.Ying L., Hofseth L.J. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007; 67: 1407-10. Doi: 10.1158/0008-5472.CAN-06-2149.